Characterization of regulatory T cells in urban newborns

Ngoc P Ly1, Begona Ruiz-Perez, Rachel M McLoughlin

  • 1Pediatric Pulmonary Medicine, University of California San Francisco Children's Hospital and UCSF Medical School, San Francisco, CA, USA. lyn@peds.ucsf.edu.

Insights

Newborns in urban areas have immature T regulatory (Treg) cells, impacting their immune function. This study compared Treg cells in urban newborns and their mothers, revealing functional deficits in infants that may influence asthma risk.

Area of Science:

  • Immunology
  • Pediatrics
  • Environmental Health

Background:

  • Asthma prevalence is high in US urban children.
  • Impaired T regulatory (Treg) cells at birth may contribute to asthma development in urban infants.
  • The study investigated Treg cells in urban newborns and their mothers.

Purpose of the Study:

  • To compare the phenotype and function of Treg cells in the cord blood of urban newborns with those in the peripheral blood of their mothers.
  • To identify potential immune mechanisms underlying asthma risk in urban children.

Main Methods:

  • Quantified Treg cell numbers, expression of markers (CD45RA, CD45RO, CD69, HLA-DR), and suppressive function in urban newborns and mothers.
  • Utilized flow cytometry to analyze Treg cell populations.
  • Assessed Treg suppressive capacity by measuring lymphocyte proliferation.

Main Results:

  • Newborns had similar FOXP3+ cell counts but fewer CD4+CD25+bright cells compared to mothers.
  • Newborn Treg cells showed a naive (CD45RA+) phenotype, unlike the activated/memory phenotype in mothers.
  • Newborns exhibited reduced TGF-beta production and impaired Treg suppression of lymphocyte proliferation.

Conclusions:

  • U.S. urban newborns possess Treg cells with an immature phenotype and reduced function compared to their mothers.
  • These findings suggest potential immune dysregulation at birth in urban infants.
  • Further longitudinal studies are necessary to understand Treg cell maturation and its link to atopic disease risk.
Abstract